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Abstract Although stability is critical for in vivo application of
immunotoxins, a thermodynamic description of their folding/
stability is still lacking. We applied di¡erential scanning calo-
rimetry (DSC) to RNase-based immunofusion comprising bar-
nase, cytotoxic RNase from Bacillus amyloliquefaciens, fused to
the light chain variable domain (VL) of anti-human ferritin anti-
body F11. By analyzing DSC curves recorded with or without
preheating and addition of the barnase-stabilizing ligand guano-
sine 3P-monophosphate, we (i) assigned two well-resolved ther-
mal transitions to the VL and barnase modules of VL-barnase,
(ii) demonstrated independent folding of these two modules, and
(iii) showed altered stability of the barnase module, which re-
sulted from the dimeric state of VL-barnase.
- 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Antibody fragments fused to toxins constitute a novel class
of chimeric molecules designed for targeted cancer therapy.
As an alternative to bacterial and plant toxins, RNases were
shown to be promising toxic modules of immunotoxins, as
reviewed in [1,2]. Several members of the RNase family in-
cluding fungal, mammalian and human enzymes were fused to
antibody fragments to obtain immunotoxins capable of killing
tumor cells (e.g. see [3^9] and references therein). Bacterial
RNase from Bacillus amyloliquefaciens, barnase, was used to
provide cytotoxicity for murine ¢broblasts [10]. Human and
mammalian RNases are considered less immunogenic for hu-
mans [3,5,11,12], and barnase allows escape from RNase in-
hibitors present in mammalians [1,2]. Furthermore, barnase as
a small (V12.4 kDa) and monomeric bacterial protein is
thought to be more consistent with a bacterial expression
system.
The most frequently used design of a recognition module in
immunotoxins involves single-chain Fv (scFv) antibody frag-
ments that comprise antibody heavy and light chain variable
domains (VH and VL) linked through a £exible peptide into a
single-chain protein ([13,14], for a review). However, Brink-
mann et al. [15] demonstrated that the immunotoxin compris-
ing the VL domain and truncated Pseudomonas exotoxin dis-
played higher antigen-binding a⁄nity than the VH-based
immunotoxin. We have recently shown that the recombinant
VL domain derived from the anti-human ferritin antibody
F11 [16,17] and fused to the N-terminus of barnase yielded
a protein that retained both RNA-degrading and antigen-
binding activities but possessed lower pH stability [18]. VL-
barnase comprises a single-domain recognition module and a
small cytotoxic domain, thus providing an immunotoxin de-
sign ideally suited for extended folding/stability studies.
Stability is a key feature that provides survival of immuno-
toxins following in vivo injection. An immunotoxin should
possess enough stability under a variety of in vivo conditions
that might result in aggregation at the physiological temper-
ature, proteolytic degradation, and conformational alterations
after internalization by a target cell. Furthermore, Willuda et
al. [19] demonstrated that thermal stability of scFv fragments
is critical for successfully targeting tumor cells. Moreover,
completely folded conformation could not be generalized for
all antibody variable domains, considering a large diversity of
antigen-binding sites and their contribution to domain stabil-
ity (e.g. see [16,17,20^22]). In this context, a high resolution
method of di¡erential scanning calorimetry (DSC) would pro-
vide a reliable means for description of folding and stability of
chimeric immunotoxins and constituent domains. This meth-
od is of particular value for establishing the extent of struc-
tural interactions between constituent modules of chimeric
immunotoxins and other multidomain proteins. In the only
study known so far to directly address this matter in immu-
notoxins, Brinkmann et al. [23] demonstrated independent
folding of the truncated Pseudomonas exotoxin and scFv frag-
ment through functional measurements that revealed distinct
folding kinetics for these two constituent modules. In the
present work, we employed DSC for a description of folding
and stability of VL-barnase fusion in comparison with the
isolated individual components, the VL domain and barnase,
with special emphasis placed on interactions between homol-
ogous and heterologous domains. We provide the ¢rst calori-
metric demonstration for independent folding of the cytotoxic
and antigen recognition modules in an RNase-based immuno-
fusion. Furthermore, we demonstrate altered stability of the
RNase module with no alterations in folding/stability ob-
served for the recognition module.
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2. Materials and methods
2.1. Expression and puri¢cation procedures
VL-barnase was expressed in Escherichia coli BL21(DE3) cells. In
order to escape from potential cytotoxicity of barnase for the host
cells, the expression plasmid pET(VL-barnase) comprised, in addition
to the VL-barnase-encoding DNA insert, the gene of barstar, a small
protein (89 amino acids, V10 kDa) that constitutes a cytoplasmic
inhibitor of barnase in bacterial cells. In similar inhibitory expression
systems, barstar was expressed in excess to the barnase and readily
formed a barstar^barnase complex, thereby protecting the host cell
RNA from degradation by barnase [24^26]. Host cells transformed
with the pET(VL-barnase) plasmid were grown in LB medium con-
taining 100 mg/l of ampicillin at 37‡C for 3^4 h, then isopropyl L-D-
thiogalactopyranoside was added to a ¢nal concentration of 0.5 mM.
After an additional 3^5 h at 37‡C and centrifugation at 3000Ug for
15 min, harvested cells were resuspended in 0.1 M Tris^HCl, pH 8.1,
and disintegrated by sonication. Inclusion bodies were separated from
the soluble fraction of the cell lysate by centrifugation for 30 min at
40 000Ug. Typically, the expression procedure yielded 25^30 mg of
soluble VL-barnase per liter of the cell culture. The soluble fraction
comprising VL-barnase and co-expressed barstar was dialyzed against
the binding bu¡er comprising 7 M urea in 25 mM Tris^HCl, pH 7.0,
and applied on the Ni-NTA Sepharose column equilibrated with the
same bu¡er. After washing the column with 10 volumes of the binding
bu¡er, ¢ve volumes of the same bu¡er containing 3 M guanidine
hydrochloride were passed over the column to remove barstar that
was involved in an inhibitory complex with VL-barnase and did not
comprise its own poly-His tag. Puri¢ed barstar-free VL-barnase was
obtained by elution of the column with 0.1 M of imidazole in the
binding bu¡er. The eluate did not contain barstar contamination, as
demonstrated by sodium dodecyl sulfate^polyacrylamide gel electro-
phoresis (SDS^PAGE). VL-barnase was refolded by dialysis against
0.1 M sodium phosphate for 16 h. A typical ¢nal yield of the refolded
protein wasV15 mg from 1 l of the cell culture with a purity not less
than 95% as determined by SDS^PAGE.
Puri¢cation and properties of the recombinant VL domain F11
were previously described [16,17]. The VL domain was derived from
the anti-human ferritin antibody F11 of mouse IgG2a/k subclass
[27,28]. Barnase was obtained from TG1 cells as described by Hartley
and Rogerson [29].
2.2. DSC
Measurements were performed with a DASM-4 scanning calorim-
eter (Biopribor, Pushchino, Russia) equipped with a computer inter-
face in a temperature range of 10^80‡C at a scan rate of 60 K/h. The
reference cell was ¢lled with the bu¡er used to dialyze the protein
sample. The bu¡ers used for the measurements were 0.1 M sodium
phosphate in the pH interval 7.4^5.0, 0.05 M sodium phosphate ad-
justed with 0.02 M sodium citrate in the pH range 4.9^3.5, and 0.05
M NaH2PO4^HCl in the pH interval 3.4^2.0. The heat capacity
curves were corrected for the instrumental baseline that was deter-
mined with both cells ¢lled with the bu¡er. The protein concentra-
tions varied between 0.5 and 1.8 mg/ml. The heat capacity curves were
analyzed and deconvoluted using the algorithm of Privalov and Po-
tekhin [30] and TERMCALC software supplied by the DASM-4 man-
ufacturer. Variations of individual measurements for the midpoint
transition temperature, Tm, were within 0.4‡C.
2.3. Other methods
Protein concentrations were determined from the UV absorbance
spectra using extinction coe⁄cients calculated from the amino acid
composition according to Gill and Von Hippel [31]. The extinction
coe⁄cients at 278 nm were 1.60 mg31 ml cm31 for VL-barnase, 2.15
mg31 ml cm31 for barnase and 1.22 mg31 ml cm31 for the VL do-
main.
3. Results
At pH 7.4, VL-barnase demonstrated a bimodal heat ca-
pacity curve with two well-resolved peaks centered around 47
and 60‡C (Fig. 1). We did not observe changes of thermal
transitions when the protein concentration varied in the range
from 0.5 to 1.8 mg/ml. At neutral pH, repeated calorimetric
recordings revealed poor reversibility for the high temperature
transition and no reversibility at all for the low temperature
one. Reversibility gradually increased as the pH decreased
below 5. Reversibility is generally considered to be an essen-
tial [32], yet not critical [33^35], requirement for correctly
measuring a transition enthalpy. At low pHs where thermal
unfolding was reversible (Fig. 2A), the calorimetric scan
yielded a single asymmetric peak that was resolved, by a de-
convolution procedure, into two largely overlapping two-state
transitions (Fig. 2B). Irreversibility of thermal transitions and
their clear-cut resolution at neutral pH provide the two ad-
vantages for attaining the major aims of the study that in-
volved (i) assignment of transitions to the two structural mod-
ules of VL-barnase and (ii) establishing the extent of their
structural independence. As a third aim of the study, we as-
sessed thermal stability and the amount of structure in VL-
barnase versus the individual components, VL and barnase,
through measuring Tm and partial heat capacity, Cp, param-
eters that do not critically depend on reversibility.
The value of speci¢c partial heat capacity of VL-barnase
determined at 25‡C, Cp(25‡C)= 1.34R 0.13 J/g/K, is typical
for completely folded globular proteins [30,32]. This is indica-
tive of the compact native-like fold of VL-barnase with no
solvent-exposed hydrophobic amino acids, fully consistent
with the lack of 8-anilino-1-naphthalene sulfonic acid binding
shown for VL-barnase under physiological conditions [18].
Thermal unfolding of the isolated VL domain of the anti-
ferritin antibody F11 occurred with a Tm around 60‡C [16],
consistent with what was reported for the human VL domain
proteolytically derived from the Bence Jones protein IVA [36].
For VL-barnase at neutral pH, the second peak around 60‡C
is therefore attributable to the melting of the VL module. To
unambiguously assign the ¢rst peak of thermal unfolding ob-
served around 47‡C, we analyzed thermal unfolding of VL-
barnase in the presence of guanosine 3P-monophosphate
(GMP), the barnase inhibitor that is known to tightly bind
to barnase with enhancement of its thermal stability [37].
Adding GMP shifted the ¢rst peak up to 50‡C (Fig. 1, inset),
thus assigning this peak to thermal unfolding of the barnase
Fig. 1. Partial reversibility of thermal unfolding for VL-barnase at
pH 7.4 (main panel) and selective stabilization of the barnase mod-
ule (inset) by adding GMP.
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module. Binding of GMP did not alter the second peak, con-
sistent with its attribution to the melting of the VL module.
The signi¢cantly higher square under the ¢rst peak (Fig. 1)
assigned to thermal unfolding of the barnase module is quite
consistent with the unusually high calorimetric enthalpy of
individual barnase. Previous calorimetric measurements at
pH 5.0^5.5 [37,38] gave enthalpy values of 42.6^43.9 J/g,
which are virtually identical to our data obtained with indi-
vidual barnase under the same conditions (not shown). These
values of unfolding enthalpy signi¢cantly exceed the range of
20^30 J/g generally found for calorimetric enthalpies of many
globular proteins [30,32]. On the other hand, the thermal un-
folding enthalpy for our VL in isolation (15.9 J/g at pH 5^7
[17]) is slightly below the lower limit of this range, which is
again fully consistent with the smaller second peak (Fig. 1).
Thus, distinct squares under the peaks provide further yet
indirect support for their assignment.
The excess heat capacity curve of VL-barnase strongly dif-
fered from that of the equimolar mixture of barnase and the
VL domain, as well as from the theoretical curve calculated
using the two curves recorded for the individual components
(Fig. 3A,B). In view of the closely similar calorimetric curves
obtained for individual VL and the VL module involved into
the fusion protein (Fig. 3B), this di¡erence suggests conforma-
tional changes in the barnase module within the fusion versus
individual barnase. One conformational feature that obviously
contributes to these changes is a signi¢cantly lower thermal
stability of the barnase module, as demonstrated by a decrease
in the Tm (47‡C versus 53‡C observed for individual barnase).
This thermal destabilization of the barnase module within VL-
barnase after the fusion is an essential observation which is
consistent with a fusion-induced decrease in pH stability of
VL-barnase [18].
Interestingly, the Tm value of the barnase module of VL-
barnase demonstrated an V5‡C increase up to Tm = 52‡C on
going from pH 7.4 to pH 5.0, a property that we also ob-
served for individual barnase (not shown). This increase in
stability might be essential for in vivo application of barnase
immunofusions considering that pH 4.6^5.5 or even lower was
found in endosomes following protein internalization [39,40].
Is folding of the two heterologous modules of VL-barnase
independent, or, alternatively, do folding-related interactions
exist between the modules? To address this question, we em-
ployed irreversibility, at neutral pH, of the low temperature
transition that belongs to unfolding of the barnase module
(Fig. 4). After preheating of VL-barnase in a calorimetric
cell up to 51‡C followed by cooling down and a second heat-
ing, irreversibility resulted in disappearance of a calorimetri-
cally revealed structure of the barnase module, with no
changes observed for thermal unfolding of the VL module
(Fig. 4B). These data strongly suggest independent folding
of the two heterologous modules, VL and barnase, within
Fig. 2. Reversibility of thermal unfolding of VL-barnase at pH 2.0
as demonstrated by the two consecutive scans (A) and deconvolu-
tion of the excess heat capacity curve (B). The latter curve was de-
rived from the heat capacity recording shown in A. The overall de-
naturation enthalpy (A) is 9.6 J/g. The enthalpies of the individual
two-state transitions obtained by deconvolution (B) are 3.8 J/g and
5.8 J/g, and the Tm values are 28.2‡C and 29.7‡C.
Fig. 3. A: Excess heat capacity curves obtained at pH 7.4 for VL-
barnase, equimolar mixture of the VL domain and barnase, and the
calculated curve generated from the sum of individual VL and bar-
nase DSC curves. B: Excess heat capacity curves of VL-barnase
(the same as in A) versus the individual components, VL and bar-
nase, at pH 7.4.
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the fusion protein, consistent with their functional indepen-
dence [18] and GMP-induced thermal stabilization of the bar-
nase module that occurred independently of the VL module
(Fig. 1).
4. Discussion
VL-barnase is a chimeric protein that belongs to a recently
reported family of RNase-based immunofusions and involves
the two heterologous proteins, a cytotoxic enzyme, bacterial
RNase, fused to the VL domain derived from the anti-human
ferritin antibody F11. Functional activities of the two heter-
ologous modules of the chimeric protein remained unchanged
versus individual VL and barnase [18]. Consistent with the
functional independence of the two modules of VL-barnase,
here we demonstrate their independent folding into a fully
compact conformation. Retention of the two activities, anti-
gen binding and RNA degradation, together with complete
folding of the two structural modules constitute the two key
features that are obligatory to consider RNase-based immu-
nofusion a promising agent for tumor cytotoxicity studies.
Despite the structurally minimal design of our immunofu-
sion that comprises the two single-domain modules, the chi-
meric protein dimerizes [18] due to the inherently high dimer-
ization propensity of the VL domain [17]. The dimeric state of
VL-barnase raises the question of whether homologous inter-
actions between the two identical modules occur and, if they
do, whether they alter stability. While the individual VL do-
main F11 retains the dimeric state both in isolation and within
the fusion protein, individual ligand-free barnase is a mono-
meric protein. In the present work, we demonstrate that in-
volvement of barnase into the dimeric VL-barnase construct
resulted in a decrease of thermal stability. This decrease is
attributed to the barnase module of the fusion protein, not
to the VL moiety whose stability remained unaltered by fu-
sion. To explain the markedly lower thermal stability of the
barnase module within the dimeric VL-barnase, the two fol-
lowing observations should be considered. First, the isolated
VL homodimer and the VL module within VL-barnase dis-
play the same calorimetric parameters, Tm and the square
under the peak (Fig. 3B). Second, independent folding of
the two heterologous modules, VL and barnase, revealed by
both the repetitive scans of VL-barnase (Fig. 4) and GMP-
induced changes in stability (Fig. 1), strongly suggests the lack
of interactions between the two heterologous modules. There-
fore, we have no alternative but to assign the thermal desta-
bilization of the barnase moiety to homologous barnase^bar-
nase interactions within the VL-barnase dimer. Destabilizing
barnase^barnase interactions might either underlie or be re-
lated to the lower pH stability of VL-barnase that we have
recently shown [18].
It is commonly believed that to provide enough stability
after in vivo injection, a therapeutic protein should possess
a Tm at least 10‡C above the physiological temperature. In
this context, a Tm of 47‡C obtained for the barnase module of
our VL-barnase implies marginal thermal stability, thus indi-
cating that stabilizing mutagenesis of the barnase module
would be bene¢cial. Interestingly, the barnase module ap-
peared more stable (by V5‡C in terms of Tm) at pH 5, the
pH value which is close to that observed in endosomes follow-
ing internalization of a ligand bound to its target on a cell
membrane [39,40]. Therefore, the intracellular stability of VL-
barnase might appear higher that the extracellular one.
In summary, using VL-barnase as a model of an immuno-
toxin suitable for folding/stability studies, we obtained the
¢rst calorimetric evidence for independent folding of cytotoxic
and recognition modules of an immunofusion comprising
RNase and an antibody fragment. Furthermore, we demon-
strated that the VL-driven dimerization of the immunofusion
destabilizes the RNase, not the VL moiety, through a mech-
anism that involves homologous interactions within the
RNase module, with no interactions of the heterologous mod-
ules being observed.
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